Fishawack Health rearranges operations as a global commercialisation partner for the life-sciences industry

Healthcare Communications

Fishawack Health has rearranged business operations as a leading global commercialisation partner for the life-sciences industry; in response to the customer demand for a more flexible, integrated service delivery, enhanced by the changes fueled by the pandemic in the healthcare scene.

A brand new persona encapsulated by the 'Less Speak... More Teeth' campaign was introduced by Fishawack Health to launch the latest offering, which highlights the ability of the company to adapt to its customers' changing needs with agility and accuracy.

“Fishawack Health rearranges operations as a global commercialisation partner for the life-sciences industry.“

The current positioning was validated by the organisation's research on how COVID-19 will affect the future of the life sciences industry and has conducted research with consumers around the industry, over the past 8 eight weeks, to understand how they are responding to the stresses introduced by the pandemic. The study revealed major disruptions, exposing long-term implications for clinical growth, the consumer journey, patient pathways, and launch and go-to-market models.

The new Fishawack Health puts all of the component capabilities of the group companies together into an integrated offering, organised into consulting, commercial and medical operating units, driven by an integrated team of experts in science.

Gail Flockhart, Fishawack Health Group President, stated: “Now more than ever, our clients need a partner with the agility, entrepreneurial spirit and expertise of a specialist agency, but with the reach and resources of a larger network. We’re able to recognize changes in the environment and plot a new direction quickly. Larger networks are not designed to adapt in this way. Our global cross-functional teams have delivered solutions designed to overcome the disruptions evident across the industry. Most teams are formed to operate within a single mode of action. Fishawack speciality teams are expected to function in 2 modes, individually and in combination with other specialties.”

Oliver Dennis, Fishawack Health CEO, stated: “We are a new breed of commercialisation partner and can help healthcare companies navigate what is a rugged landscape. We’re designed to solve these challenges by providing integrated, agile solutions across the entire product life cycle from clinical development to loss of patent.”

See all the latest jobs in Healthcare Communications
Return to news